123 related articles for article (PubMed ID: 8993570)
41. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
42. PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents.
Keller H; Devchand PR; Perroud M; Wahli W
Biol Chem; 1997 Jul; 378(7):651-5. PubMed ID: 9278144
[TBL] [Abstract][Full Text] [Related]
43. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
[TBL] [Abstract][Full Text] [Related]
44. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
[TBL] [Abstract][Full Text] [Related]
45. Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues.
Amsaguine-Safir S; Bianchi A; Collet P; Huin-Schohn C; Jeanvoine A; Bécuwe P; Krémarik-Bouillaud P; Domenjoud L; Keller JM; Schohn H; Dauça M
Microsc Res Tech; 2003 Jun; 61(2):185-90. PubMed ID: 12740825
[TBL] [Abstract][Full Text] [Related]
46. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes.
Marcus SL; Miyata KS; Rachubinski RA; Capone JP
Gene Expr; 1995; 4(4-5):227-39. PubMed ID: 7787415
[TBL] [Abstract][Full Text] [Related]
47. Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero.
Schmuth M; Schoonjans K; Yu QC; Fluhr JW; Crumrine D; Hachem JP; Lau P; Auwerx J; Elias PM; Feingold KR
J Invest Dermatol; 2002 Dec; 119(6):1298-303. PubMed ID: 12485431
[TBL] [Abstract][Full Text] [Related]
48. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.
Sher T; Yi HF; McBride OW; Gonzalez FJ
Biochemistry; 1993 Jun; 32(21):5598-604. PubMed ID: 7684926
[TBL] [Abstract][Full Text] [Related]
49. The peroxisome proliferator-activated receptors: ligands and activators.
Forman BM; Chen J; Evans RM
Ann N Y Acad Sci; 1996 Dec; 804():266-75. PubMed ID: 8993549
[TBL] [Abstract][Full Text] [Related]
50. Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor alpha-deficient mice upon lipopolysaccharide and clofibrate challenges.
Cui X; Kawashima H; Barclay TB; Peters JM; Gonzalez FJ; Morgan ET; Strobel HW
J Pharmacol Exp Ther; 2001 Feb; 296(2):542-50. PubMed ID: 11160642
[TBL] [Abstract][Full Text] [Related]
51. Targeted disruption of the peroxisomal fatty acyl-CoA oxidase gene: generation of a mouse model of pseudoneonatal adrenoleukodystrophy.
Fan CY; Pan J; Chu R; Lee D; Kluckman KD; Usuda N; Singh I; Yeldandi AV; Rao MS; Maeda N; Reddy JK
Ann N Y Acad Sci; 1996 Dec; 804():530-41. PubMed ID: 8993571
[No Abstract] [Full Text] [Related]
52. Peroxisome proliferator activated receptor-alpha expression in human liver.
Palmer CN; Hsu MH; Griffin KJ; Raucy JL; Johnson EF
Mol Pharmacol; 1998 Jan; 53(1):14-22. PubMed ID: 9443928
[TBL] [Abstract][Full Text] [Related]
53. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.
Miller CW; Ntambi JM
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9443-8. PubMed ID: 8790349
[TBL] [Abstract][Full Text] [Related]
54. Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice.
DeLuca JG; Doebber TW; Kelly LJ; Kemp RK; Molon-Noblot S; Sahoo SP; Ventre J; Wu MS; Peters JM; Gonzalez FJ; Moller DE
Mol Pharmacol; 2000 Sep; 58(3):470-6. PubMed ID: 10953038
[TBL] [Abstract][Full Text] [Related]
55. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
Muroya Y; Ito O
Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064
[TBL] [Abstract][Full Text] [Related]
56. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
Guan Y
Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
[TBL] [Abstract][Full Text] [Related]
57. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Princen HM; Kooistra T
Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
[TBL] [Abstract][Full Text] [Related]
58. Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing.
Reddy JK
Am J Pathol; 2004 Jun; 164(6):2305-21. PubMed ID: 15161663
[No Abstract] [Full Text] [Related]
59. Structure of the mouse peroxisome proliferator activated receptor alpha gene.
Gearing KL; Crickmore A; Gustafsson JA
Biochem Biophys Res Commun; 1994 Feb; 199(1):255-63. PubMed ID: 8123021
[TBL] [Abstract][Full Text] [Related]
60. Studies on the role of PPAR in the fibrate-modulated gene expression of apolipoprotein A-I, plasminogen activator inhibitor 1, and fibrinogen in primary hepatocyte cultures from cynomolgus monkey.
Kockx M; Princen HM; Kooistra T
Ann N Y Acad Sci; 1996 Dec; 804():711-2. PubMed ID: 8993601
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
